首页> 外文OA文献 >>CXCL12/CXCR4 Axis-Targeted Dual-Functional Nano-Drug Delivery System Against Ovarian Cancer

【2h】

>CXCL12/CXCR4 Axis-Targeted Dual-Functional Nano-Drug Delivery System Against Ovarian Cancer

机译：> CXCL12 / CXCR4轴针对卵巢癌的双官能纳米药物递送系统

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Jiyang Xue; Ruixiang Li; Dingding Gao; Fenghua Chen; Hongjuan Xie;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. CXCL12/CXCR4 Axis-Targeted Dual-Functional Nano-Drug Delivery System Against Ovarian Cancer [J] . Jiyang Xue, Ruixiang Li, Dingding Gao, International Journal of Nanomedicine . 2020,第1期

机译：CXCL12 / CXCR4轴针对卵巢癌的双功能纳米药物输送系统
2. CXCL12/CXCR4 Blockade by Oncolytic Virotherapy Inhibits Ovarian Cancer Growth by Decreasing Immunosuppression and Targeting Cancer-Initiating Cells [J] . Margaret Gil, Marcin P. Komorowski, Mukund Seshadri, The journal of immunology . 2014,第10期

机译：溶瘤病毒疗法对CXCL12 / CXCR4的阻滞通过降低免疫抑制作用和靶向癌起始细胞来抑制卵巢癌的生长。
3. CXCL12/CXCR4 blockade by oncolytic virotherapy inhibits ovarian cancer growth by decreasing immunosuppression and targeting cancer-initiating cells [J] . GilM., KomorowskiM.P., SeshadriM., The Journal of Immunology: Official Journal of the American Association of Immunologists . 2014,第10期

机译：溶瘤病毒疗法对CXCL12 / CXCR4的阻滞通过降低免疫抑制和靶向癌症起始细胞来抑制卵巢癌的生长
4. Designing a Local Drug Delivery System for Ovarian Cancer Using Biomimetic Materials [C] . Eva Christabel Williams, Ryan Toomey, Norma Alcantar American Institute of Chemical Engineers Annual Meeting . 2007

机译：使用仿生材料设计卵巢癌的局部药物递送系统
5. Molecular targeting of drug delivery systems to ovarian cancer by BH3 and LHRH peptides. [D] . Dharap, Sonia. 2005

机译：BH3和LHRH肽对卵巢癌药物递送系统的分子靶向作用。
6. CXCL12/CXCR4 Blockade by Oncolytic Virotherapy Inhibits Ovarian Cancer Growth by Decreasing Immunosuppression and Targeting Cancer Initiating Cells [O] . Margaret Gil, Marcin P. Komorowski, Mukund Seshadri, -1

机译：溶瘤病毒疗法对CXCL12 / CXCR4的阻断通过降低免疫抑制作用和靶向癌症起始细胞来抑制卵巢癌的生长。
7. CXCL12/CXCR4 blockade by oncolytic virotherapy inhibits ovarian cancer growth by decreasing immunosuppression and targeting cancer-initiating cells [O] . Gil, Margaret, Komorowski, Marcin P., Seshadri, Mukund, 2014

机译：溶瘤病毒疗法对CXCL12 / CXCR4的阻滞通过降低免疫抑制和靶向癌症起始细胞来抑制卵巢癌的生长
8. Imaging CXCL12-CXCR4 Signaling and Inhibition in Ovarian Cancer. [R] . Luker, G. 2013

机译：成像CXCL12-CXCR4在卵巢癌中的信号和抑制。

>CXCL12/CXCR4 Axis-Targeted Dual-Functional Nano-Drug Delivery System Against Ovarian Cancer

著录项

引文网络

相似文献

相关主题

期刊订阅